Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.99
Delayed Data
As of May 27
 +0.325 / +3.75%
Today’s Change
5.05
Today|||52-Week Range
9.00
+14.23%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 9.00. The median estimate represents a +11.23% increase from the last price of 8.99.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.03
Sales
$61.0M
Reporting Date
Jul 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.57%
 
 
 
 
 
 
Growthannually 104.77%
 
 
 
 
 
 

Sales

Growthquarterly 2.13%
 
 
 
 
 
 
Growthannually 148.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.